Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-32,313
Closed -$735K 1950
2026
Q1
$735K Buy
+32,313
New +$764K 0.01% 688
2025
Q3
Sell
-37,370
Closed -$1.17M 1300
2025
Q2
$1.17M Buy
37,370
+23,433
+168% +$775K 0.02% 538
2025
Q1
$533K Buy
+13,937
New +$591K 0.02% 778
2024
Q4
Sell
-7,563
Closed -$326K 1878
2024
Q3
$326K Buy
+7,563
New +$337K 0.01% 1526
2024
Q2
Sell
-8,488
Closed -$530K 2174
2024
Q1
$530K Sell
8,488
-427
-5% -$25.6K 0.01% 967
2023
Q4
$499K Buy
+8,915
New +$444K 0.01% 960
2021
Q2
Sell
-3,993
Closed -$301K 1440
2021
Q1
$301K Buy
+3,993
New +$293K 0.01% 765

Other funds holding ENOV

Centiva Capital's ENOV Position: Q2 2026 in Review

Centiva Capital sold out of Enovis (ENOV) in Q2 2026, closing a stake of 32,313 shares — an estimated $735K sold.

Centiva Capital first reported a position in ENOV in Q1 2021 and held it in 7 quarters. The position peaked at $1.17M in Q2 2025. 253 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • Centiva Capital reported no remaining Enovis position as of Q2 2026 after selling out during the quarter.
  • Centiva Capital sold 32,313 Enovis shares in Q2 2026, an estimated $735K.
  • Centiva Capital first reported a position in Enovis in Q1 2021 and held it in 7 quarters.
  • Centiva Capital's Enovis position peaked at $1.17M in Q2 2025.
  • 253 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.